These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 10975587)

  • 41. Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR study: a multicenter, randomized, double-blind placebo-controlled trial. Multicenter European Research Trial with Cilazapril after Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group.
    Circulation; 1992 Jul; 86(1):100-10. PubMed ID: 1535568
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hemodynamic effects of alpha1-adrenoceptor antagonist, doxazosin, in patients with chronic congestive heart failure.
    Kieback AG; Rödiger O; Jaenecke H; Grohmann A; Wernecke KD; Baumann G; Felix SB
    J Cardiovasc Pharmacol; 2005 Oct; 46(4):399-404. PubMed ID: 16160589
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Restenosis and clinical outcome in patients treated with amlodipine after angioplasty: results from the Coronary AngioPlasty Amlodipine REStenosis Study (CAPARES).
    Jørgensen B; Simonsen S; Endresen K; Forfang K; Vatne K; Hansen J; Webb J; Buller C; Goulet G; Erikssen J; Thaulow E
    J Am Coll Cardiol; 2000 Mar; 35(3):592-9. PubMed ID: 10716459
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Echocardiography-dobutamine test in the short-term evaluation of the results of coronary angioplasty].
    Lanzarini L; Fetiveau R; Previtali M; Poli A; Mussini A; Ferrario M; Bramucci E; Montemartini C
    G Ital Cardiol; 1994 Feb; 24(2):107-14. PubMed ID: 8013762
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intracoronary dipyridamole reduces the incidence of abrupt vessel closure following PTCA: a prospective randomised trial.
    Heintzen MP; Heidland UE; Klimek WJ; Leschke M; Kelm M; Schwartzkopff B; Vester EG; Michel CJ; Strauer BE
    Heart; 2000 May; 83(5):551-6. PubMed ID: 10768906
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Concept of maximal flow ratio for immediate evaluation of percutaneous transluminal coronary angioplasty result by videodensitometry.
    Pijls NH; Aengevaeren WR; Uijen GJ; Hoevelaken A; Pijnenburg T; van Leeuwen K; van der Werf T
    Circulation; 1991 Mar; 83(3):854-65. PubMed ID: 1999036
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognostic value of intracoronary flow velocity and diameter stenosis in assessing the short- and long-term outcomes of coronary balloon angioplasty: the DEBATE Study (Doppler Endpoints Balloon Angioplasty Trial Europe).
    Serruys PW; di Mario C; Piek J; Schroeder E; Vrints C; Probst P; de Bruyne B; Hanet C; Fleck E; Haude M; Verna E; Voudris V; Geschwind H; Emanuelsson H; Mühlberger V; Danzi G; Peels HO; Ford AJ; Boersma E
    Circulation; 1997 Nov; 96(10):3369-77. PubMed ID: 9396429
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Augmented myocardial perfusion reserve after coronary angioplasty quantified by positron emission tomography with H2(15)O.
    Walsh MN; Geltman EM; Steele RL; Kenzora JL; Ludbrook PA; Sobel BE; Bergmann SR
    J Am Coll Cardiol; 1990 Jan; 15(1):119-27. PubMed ID: 2295720
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Coronary stenosis vasomotion during dynamic exercise before and after PTCA.
    Suter TM; Hess OM; Bortone A; Nonogi H; Grimm J; Krayenbuehl HP
    Eur Heart J; 1989 Dec; 10 Suppl G():58-63. PubMed ID: 2627951
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The role of myocardial perfusion imaging in the evaluation of patients undergoing percutaneous transluminal coronary angioplasty.
    Fard-Esfahani A; Assadi M; Saghari M; Mohagheghie A; Fallahi B; Eftekhari M; Beiki D; Takavar A; Nabipour I; Ebrahimi A; Izadyar S; Ansari-Gilani K
    Hellenic J Cardiol; 2009; 50(5):396-401. PubMed ID: 19767281
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Relationship of thallium-201 clearance on exercise stress myocardial scintigraphy to coronary flow reserve in patients with coronary artery disease.
    Inoue T; Fujito T; Hoshi K; Yamaguchi H; Sakai Y; Takayanagi K; Morooka S
    Coron Artery Dis; 1996 Mar; 7(3):257-63. PubMed ID: 8827413
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prevention of restenosis after coronary balloon angioplasty: rationale and design of the Fluvastatin Angioplasty Restenosis (FLARE) Trial. The FLARE Study Group.
    Foley DP; Bonnier H; Jackson G; Macaya C; Shepherd J; Vrolix M; Serruys PW
    Am J Cardiol; 1994 May; 73(14):50D-61D. PubMed ID: 8198025
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of late percutaneous transluminal coronary angioplasty of an occluded infarct-related coronary artery on left ventricular function in patients with a recent (< 6 weeks) Q-wave acute myocardial infarction (Total Occlusion Post-Myocardial Infarction Intervention Study [TOMIIS]--a pilot study).
    Dzavik V; Beanlands DS; Davies RF; Leddy D; Marquis JF; Teo KK; Ruddy TD; Burton JR; Humen DP
    Am J Cardiol; 1994 May; 73(12):856-61. PubMed ID: 8184807
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impaired coronary blood flow in nonculprit arteries in the setting of acute myocardial infarction. The TIMI Study Group. Thrombolysis in myocardial infarction.
    Gibson CM; Ryan KA; Murphy SA; Mesley R; Marble SJ; Giugliano RP; Cannon CP; Antman EM; Braunwald E
    J Am Coll Cardiol; 1999 Oct; 34(4):974-82. PubMed ID: 10520778
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical significance of perfusion defects by thallium-201 single photon emission tomography following oral dipyridamole early after coronary angioplasty.
    Jain A; Mahmarian JJ; Borges-Neto S; Johnston DL; Cashion WR; Lewis JM; Raizner AE; Verani MS
    J Am Coll Cardiol; 1988 May; 11(5):970-6. PubMed ID: 2965717
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Low molecular weight heparin (reviparin) in percutaneous transluminal coronary angioplasty. Results of a randomized, double-blind, unfractionated heparin and placebo-controlled, multicenter trial (REDUCE trial). Reduction of Restenosis After PTCA, Early Administration of Reviparin in a Double-Blind Unfractionated Heparin and Placebo-Controlled Evaluation.
    Karsch KR; Preisack MB; Baildon R; Eschenfelder V; Foley D; Garcia EJ; Kaltenbach M; Meisner C; Selbmann HK; Serruys PW; Shiu MF; Sujatta M; Bonan R
    J Am Coll Cardiol; 1996 Nov; 28(6):1437-43. PubMed ID: 8917255
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Coronary circulatory dynamics before and after successful coronary angioplasty.
    Williams DO; Riley RS; Singh AK; Most AS
    J Am Coll Cardiol; 1983 May; 1(5):1268-72. PubMed ID: 6131913
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intracoronary Doppler- and quantitative coronary angiography-derived predictors of major adverse cardiac events after stent implantation.
    Haude M; Baumgart D; Verna E; Piek JJ; Vrints C; Probst P; Erbel R
    Circulation; 2001 Mar; 103(9):1212-7. PubMed ID: 11238263
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hemodynamic interaction between a daily dosed phosphodiesterase 5 inhibitor, tadalafil, and the alpha-adrenergic blockers, doxazosin and tamsulosin, in middle-aged healthy male subjects.
    Guillaume M; Lonsdale F; Darstein C; Jimenez MC; Mitchell MI
    J Clin Pharmacol; 2007 Oct; 47(10):1303-10. PubMed ID: 17906163
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of doxazosin on exercise-induced angina pectoris, ST-segment depression, and insulin sensitivity in patients with syndrome X.
    Bøtker HE; Sonne HS; Schmitz O; Nielsen TT
    Am J Cardiol; 1998 Dec; 82(11):1352-6. PubMed ID: 9856918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.